# OnCo record ose2101 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ose2101/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ose2101" ;
  schema:name "OSE2101"@en ;
  schema:description "OSE2101 is an experimental cancer vaccine from OSE Immunotherapeutics in phase 3 trials for non-small-cell lung cancer, aimed at HER2 and CEACAM5."@en ;
  schema:url <https://onco.cc/drugs/ose2101/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=OSE2101>, <https://www.ose-immuno.com/en/pipeline/tedopi/> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "vaccine" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/ceacam5/>, <https://onco.cc/targets/tp53/> ;
  onco:companies <https://onco.cc/companies/ose-immunotherapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06472245/>, <https://onco.cc/trials/nct05751798/> .